6th Age-Related Disease Therapeutics Summit Hyatt Centric Fisherman’s Wharf San Francisco, San Francisco

Event Starts In

In 2024, age-related disease biotechs are set to shine, building on 2023’s milestones such as Eli Lilly’s partnership with BioAge to test muscle rejuvenation therapy and Chan Zuckerberg Biolabs tapping into immune cell engineering to eradicate age-related diseases.

To successfully navigate the volatile market of 2024, rapid proof-of-concept studies and validated clinical endpoints are crucial for funding and pipeline progress.

The 6th Age-Related Disease Therapeutics Summit is returning to San Francisco in June, with 60+ participants including Eli Lilly, Takeda, and Turn Biosciences to dive deep into breakthroughs in cellular programming, senolytic pathways, and epigenetic effects. Explore biomarkers, navigate regulations, and foster collaborations for pipeline support and commercialization.

This is your definitive age-related disease therapeutics forum to gain unparalleled competitive intelligence, scientific advancements and form meaningful partnerships to solve humankind’s fundamental problem.

⌛ Event Dates & Venue

11 Jun - 13 Jun 2024, 9:00 am - 4:00 pm

💸 Website & Tickets

Go to Event Website
Ticket Pricing:
Conference + 2 Workshops - Drug Developer Pricing: USD 3797.00, Conference + 1 Workshop - Drug Developer Pricing: USD 3398.00, Conference Only - Drug Developer Pricing: USD 2999.00, Conference + 2 Workshops - Solution Provider Pricing: USD 4631.00, Conference + 1 Workshop - Solution Provider Pricing: USD 4166.00, Conference Only - Solution Provider Pricing: USD 3699.00

◑ Topics | Categories